These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17712869)

  • 1. Enzyme-responsive PARACEST MRI contrast agents: a new biomedical imaging approach for studies of the proteasome.
    Yoo B; Raam MS; Rosenblum RM; Pagel MD
    Contrast Media Mol Imaging; 2007 Jul; 2(4):189-98. PubMed ID: 17712869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide.
    Liu G; Li Y; Pagel MD
    Magn Reson Med; 2007 Dec; 58(6):1249-56. PubMed ID: 18046705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PARACEST MRI contrast agent to detect enzyme activity.
    Yoo B; Pagel MD
    J Am Chem Soc; 2006 Nov; 128(43):14032-3. PubMed ID: 17061878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart Contrast Agents for Magnetic Resonance Imaging.
    Bonnet CS; Tóth É
    Chimia (Aarau); 2016; 70(1-2):102-8. PubMed ID: 26931225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo detection of MRI-PARACEST agents in mouse brain tumors at 9.4 T.
    Li AX; Suchy M; Li C; Gati JS; Meakin S; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2011 Jul; 66(1):67-72. PubMed ID: 21254213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects and limitations of paramagnetic chemical exchange saturation transfer agents serving as biological reporters in vivo.
    Sherry AD; Castelli DD; Aime S
    NMR Biomed; 2023 Jun; 36(6):e4698. PubMed ID: 35122337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.
    Winter PM; Cai K; Chen J; Adair CR; Kiefer GE; Athey PS; Gaffney PJ; Buff CE; Robertson JD; Caruthers SD; Wickline SA; Lanza GM
    Magn Reson Med; 2006 Dec; 56(6):1384-8. PubMed ID: 17089356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantages of paramagnetic chemical exchange saturation transfer (CEST) complexes having slow to intermediate water exchange properties as responsive MRI agents.
    Soesbe TC; Wu Y; Dean Sherry A
    NMR Biomed; 2013 Jul; 26(7):829-38. PubMed ID: 23055299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo detection of PARACEST agents with relaxation correction.
    Jones CK; Li AX; Suchý M; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2010 May; 63(5):1184-92. PubMed ID: 20432289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of DT-diaphorase Enzyme with a ParaCEST MRI Contrast Agent.
    Daryaei I; Jones KM; Pagel MD
    Chemistry; 2017 May; 23(27):6514-6517. PubMed ID: 28370655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI.
    Ali MM; Yoo B; Pagel MD
    Mol Pharm; 2009; 6(5):1409-16. PubMed ID: 19298054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activity.
    Li Y; Sheth VR; Liu G; Pagel MD
    Contrast Media Mol Imaging; 2011; 6(4):219-28. PubMed ID: 21861282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-pool modeling of proton exchange processes in biological systems in the presence of MRI-paramagnetic chemical exchange saturation transfer (PARACEST) agents.
    Li AX; Hudson RH; Barrett JW; Jones CK; Pasternak SH; Bartha R
    Magn Reson Med; 2008 Nov; 60(5):1197-206. PubMed ID: 18958857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging of paraCEST agents using frequency labeled exchange transfer MRI.
    Lin CY; Yadav NN; Ratnakar J; Sherry AD; van Zijl PC
    Magn Reson Med; 2014 Jan; 71(1):286-93. PubMed ID: 23468384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance chemical exchange saturation transfer imaging and nanotechnology.
    Winter PM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):389-98. PubMed ID: 22422650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of divalent transition metal ion paraCEST MRI contrast agents.
    Dorazio SJ; Olatunde AO; Tsitovich PB; Morrow JR
    J Biol Inorg Chem; 2014 Feb; 19(2):191-205. PubMed ID: 24253281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized MRI contrast for on-resonance proton exchange processes of PARACEST agents in biological systems.
    Li AX; Suchy M; Jones CK; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2009 Nov; 62(5):1282-91. PubMed ID: 19780147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox- and hypoxia-responsive MRI contrast agents.
    Do QN; Ratnakar JS; Kovács Z; Sherry AD
    ChemMedChem; 2014 Jun; 9(6):1116-29. PubMed ID: 24825674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric PARACEST agents for enhancing MRI contrast sensitivity.
    Wu Y; Zhou Y; Ouari O; Woods M; Zhao P; Soesbe TC; Kiefer GE; Sherry AD
    J Am Chem Soc; 2008 Oct; 130(42):13854-5. PubMed ID: 18817395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI thermometry based on PARACEST agents.
    Zhang S; Malloy CR; Sherry AD
    J Am Chem Soc; 2005 Dec; 127(50):17572-3. PubMed ID: 16351064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.